Navigation Links
Chemists identify immune system mechanism for methamphetamine binges

Chemists at The Scripps Research Institute have found evidence in laboratory studies that the immune system may be able to recognize methamphetamine and boost tolerance to the drug through an unusual vaccine-like mechanism. Their finding, if confirmed in human studies, could help explain why chronic users go on long binges with the illicit drug, also known as speed. The study could lead to new treatments for the drug's addiction, they say.

Recent studies by others have documented the drug's apparent ability to suppress the immune system, making abusers more vulnerable to diseases such as HIV. The new study is the first to suggest that the drug can engage the body's defense system to attack methamphetamine in such a way that makes users inclined to use more of the drug, the researchers say. Their study, which paints a clearer picture of the drug's effect on the immune system and its potential for abuse, was described today at the 229th national meeting of the American Chemical Society, the world's largest scientific society.

"Test animals injected with methamphetamine actually developed antibodies to the drug, which is highly unique for a molecule of its relatively small size," says study co-leader Kim Janda, Ph.D., a chemist at Scripps in La Jolla, Calif. Developing antibodies to the body's invaders, such as viruses and bacteria, is normally a good thing and forms the basis of modern vaccines, he explains. But ironically, people who abuse methamphetamine may build up antibodies to the drug itself, so they require increasing amounts to get high, resulting in binging behavior, he says.

"Without knowing it, they're essentially vaccinating themselves against the drug, and that's not a good thing as it requires more of the drug to get high," says Janda. His findings were first reported in a recent issue of the Journal of the American Chemical Society, the Society's peer-reviewed journal.

In a test tube study designed to simulate the chemica
'"/>

Source:American Chemical Society


Page: 1 2 3

Related biology news :

1. Chemists create Superbowl molecule; May lead to better health
2. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
3. Chemists identify key gene in development of type 1 diabetes
4. Chemists synthesize molecule that helps body battle cancers, malaria
5. Fox Chase Cancer Center scientists identify immune-system mutation
6. Researchers identify target for cancer drugs
7. Scientists identify genetic pathways essential to RNA interference
8. Scientists identify molecular events that drive cell senescence
9. Scientists identify new model Of NK cell development
10. Yale researchers identify molecule for detecting parasitic infection in humans
11. Wisconsin researchers identify sleep gene

Post Your Comments:
(Date:11/23/2009)... N.H. University of New Hampshire microbiologist ...15 to advance understanding of the actinorhizal pl...rich nutrient-poor and contaminated soils. , Th...warded Tisa, a professor of molecular, cellular an...biotic relationship between the bacteria Frankia a...
(Date:11/23/2009)...ity of Southern California biomedical engineer and...a new tool to help clinicians distinguish cardiac ...ic problems manageable with drugs and lifestyle ch...erted into the arteries feeding the heart, offer a... these blood vessels, often revealing deposits of ...
(Date:11/23/2009)...s like frogs and toads have existed for 360 millio...t a new aquatic fungus is threatening to make many...ovember issue of Microbiology Today . , The fu...ound to be associated with waves of amphibian exti...alia in the 1990,s. Bd infects over 350 amphibian ...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Europe and China watching Earth together 9004 1Europe and China watching Earth together 9004 2Computers aid in cracking deception in plants 9002 1Computers aid in cracking deception in plants 9002 2ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 50067 1ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 50067 2ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 50067 3ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 50067 4
...ate red wine consumption is beneficial to cardiova...lcohol?, Take heart: laboratory research, just pre...ux, France, showed that Concord grape juice stimul...shion to red wine. The French researchers also rep...nged relaxation effect that has not yet been repor...
...researcher has developed a new technique that can ... diagnose the bacteria which causes the most commo...ce, from QUT,s Faculty of Science, has developed a... pinpoint the bacteria Campylobacter jejuni. , "C...erial food-borne gastroenteritis in westernised co...
... new biometrics to be stored on ...Domestic and global security,threats, coupled with...ading governments across the world to pursue the i...vel documents (MRTDs) to their citizens.,Entrust, ...oyment and,innovation, has announced the developme...
Other Biology News:Fighting the spread of food poisoning 2Entrust Continues Leadership by Adding Support for Next-generation E-Passports 2Entrust Continues Leadership by Adding Support for Next-generation E-Passports 3
(Date:11/24/2009)...hasbeenmetforpatientswithadvanced-stage,orrecurren...swire-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS ...mpanyfocusedonendocrinetherapyandoncology,todayann...argetedcytotoxicpeptideconjugate,AEZS-108(formerly...alcancer.Inapersonalizedhealthcareapproach,thestud...
(Date:11/24/2009)...swire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ...,announcedthatithassubmittedaMAAtotheEuropeanMedic...replacementtherapyindevelopment,forthetreatmentofT...tionforvelaglucerasealfathathasbeensubmitted,withp..., Basedonaglobalsupplyshortageofthecurrentlyappr...
(Date:11/24/2009)...24/PRNewswire-FirstCall/--GenomicHealth,Inc.(Nasda...h,sExecutiveChairman,willpresentatthe21stAnnualPip...y,December1,2009at10:00a.m.ET. ,, Toaccesstheli...visittheInvestorRelationssectionofGenomicHealth,sw...connecttothewebsiteatleast15minutespriortothebegin...
(Date:11/24/2009)...am Connects Customers with Partners Validated to P...tek Products , Ottawa, ON...ding provider of products for biological sample co...ounced its new global partner program. The program... partner community and is designed to help partner...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...obix to Acquire Commercialized Thrombolytic and Re... Million, TUCSON, Ariz., May 7 ImaRx Therapeuti...has signed a letter of intent in,which Microbix Bi...ted,assets from ImaRx for $17 million in cash. Uro...ssolving agent, indicated for the treatment of,acu...
...ng Digital Mammography Revenue Growth and FDA Appr...wth in 2008; Affirms First Half 2008 Financial ...onference Call Begins Today at 10:00 a.m. ET, NAS...dustry-leading provider of Computer-Aided Detectio...cancer, today announced financial,results for the ...
...amounts are in U.S. dollars, QUEBEC CITY, May 7 /...DAQ: AEZS , TSX: AEZ), a global biopharmaceutical...day reported financial and operating results,for t...arter 2008 Highlights, - Cetrorelix: first patien...e 3 program in benign prostatic hyperplasia (BPH);...
Other Biology Technology:ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 2ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 3ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 4iCAD Reports First Quarter 2008 Financial Results 2iCAD Reports First Quarter 2008 Financial Results 3iCAD Reports First Quarter 2008 Financial Results 4iCAD Reports First Quarter 2008 Financial Results 5iCAD Reports First Quarter 2008 Financial Results 6iCAD Reports First Quarter 2008 Financial Results 7iCAD Reports First Quarter 2008 Financial Results 8iCAD Reports First Quarter 2008 Financial Results 9AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 2AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 3AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 4AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 5AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 6AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 7
Rabbit Anti-oligophrenin-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Anti-G Protein Gi-alpha-1 Monoclonal Antibody, Unconjugated, Clone R4 from CHEMICON
Goat Anti-KOR-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Oligodendrocyte Differentiation Kit from R&D Systems
Biology Products: